Sage Journals: Discover world-class research

Open access

Research article

First published 2014

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

Pui S. Tan, Benjamin Haaland, Alberto J. Montero [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2019-9

Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer

Alisha Shivji, Raafi Ali, Scott North [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2012-6

Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert

Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio [...]

Therapeutic Advances in Urology

Open access

Research article

First published 2018

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes

Alessia Cavo, Alessandra Rubagotti, Elisa Zanardi [...]

Therapeutic Advances in Medical Oncology

Free access

Review article

First published 2014-2

Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy

Aurelius Omlin, Carmel Pezaro, Silke Gillessen Sommer

Therapeutic Advances in Urology

Open access

Review article

First published 2013

Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer

Fabien Calcagno, Thierry Nguyen, Erion Dobi [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2020-3

Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice

Halima Lahcene, Armen G Aprikian, Marie Vanhuyse [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2020-7

A castrate-resistant metastatic prostate cancer patient with severe pancytopenia,successfully treated with docetaxel chemotherapy

Anuradha Kunthur

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2021-8

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Özgecan Dülgar, Deniz Tataroğlu Özyükseler, Mustafa Başak [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-8

Abiraterone in the management of castration-resistant prostate cancer prior to chemotherapy

Benjamin A. Gartrell, Fred Saad

Therapeutic Advances in Urology

Search results